Kangmei Pharmaceutical Co., Ltd. (SHA:600518)
China · Delayed Price · Currency is CNY 1.410
0.00 (0.00%)
Jun 10, 2026, 3:00 PM CST
Kangmei Pharmaceutical Market Cap
Kangmei Pharmaceutical has a market cap or net worth of 19.5 billion as of June 10, 2026. Its market cap has decreased by -28.97% in one year.
Market Cap
19.50B
Enterprise Value
18.48B
Revenue
5.03B
Ranking
n/a
PE Ratio
n/a
Stock Price
1.41
Market Cap Chart
Since March 19, 2001, Kangmei Pharmaceutical's market cap has increased from 2.58B to 19.50B, an increase of 656.19%. That is a compound annual growth rate of 8.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 9, 2026 | 19.50B | -26.18% |
| Dec 31, 2025 | 26.41B | -18.58% |
| Dec 31, 2024 | 32.44B | 25.81% |
| Dec 29, 2023 | 25.79B | -15.45% |
| Dec 30, 2022 | 30.50B | -28.80% |
| Dec 31, 2021 | 42.84B | 221.38% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd | 23.87B |
| Zhejiang Huahai Pharmaceutical | 22.35B |
| Tasly Pharmaceutical Group | 21.20B |
| Betta Pharmaceuticals | 20.57B |
| Jilin Aodong Pharmaceutical Group | 19.90B |
| Chengdu Kanghong Pharmaceutical Group | 19.65B |
| Jiangsu Nhwa Pharmaceutical Co., LTD | 19.62B |
| Hybio Pharmaceutical | 18.96B |